Cargando…
Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection
Baek et al.(1) investigated the duration of COVID-19 virus shedding in infected patients and demonstrated that even in patients demonstrating prolonged viral clearance, the virus was no longer viable after 15 days post onset of symptoms. Our study aimed to measure whether nitric oxide nasal spray (N...
Autores principales: | Winchester, Stephen, John, Sarah, Jabbar, Kashif, John, Isaac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117664/ https://www.ncbi.nlm.nih.gov/pubmed/33992687 http://dx.doi.org/10.1016/j.jinf.2021.05.009 |
Ejemplares similares
-
Oxymetazoline Hydrochloride Combined With Mometasone Nasal Spray for Persistent Nasal Congestion (Pilot Study)
por: Rael, Efren L, et al.
Publicado: (2011) -
SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial
por: Tandon, Monika, et al.
Publicado: (2022) -
Correction to “SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial”
por: Tandon, Monika, et al.
Publicado: (2022) -
Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children
por: Zhou, Jianguo, et al.
Publicado: (2023) -
Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019
por: Abdulrab, S., et al.
Publicado: (2020)